M&A Deal Summary |
|
---|---|
Date | 2021-09-28 |
Target | DERMAdoctor |
Sector | Medical Products |
Buyer(s) | NovaBay Pharma |
Deal Type | Add-on Acquisition |
Deal Value | 15M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 2000 |
Sector | Life Science |
Employees | 24 |
Revenue | 15M USD (2023) |
NovaBay Pharmax` is a clinical-stage biopharmaceutical company focused on developing its proprietary and patented Aganocide compounds. Aganocides are novel, broad-spectrum, fast-acting, synthetic anti-infectives designed to mimic the body’s defense against infection. They are active against bacteria, fungi and viruses, and are being developed to treat and prevent a wide range of local, non-systemic infections with a low likelihood of developing bacterial resistance. NovaBay Pharmaceuticals was founded in 2000 and is based in Emeryville, California.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Medical Products) | 1 of 1 |
Type (Add-on Acquisition) | 1 of 1 |
State (Missouri) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2021) | 1 of 1 |
Size (of disclosed) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2024-03-14 |
DERMAdoctor
Riverside, Missouri, United States DERMAdoctor is a privately-held company that commercializes dermatologist-developed skin care products that produce and sells more than 30 products underlines that include Ain’t Misbehavin’, Calm Cool + Corrected, Kakadu C, KP Duty, and Wrinkle Revenge. DERMAdoctor is based in Riverside, Missouri. |
Sell | $1M |